Prusiner SB. Prions. PNAS. 1998;95:13363–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE, et al. Antisense oligonucleotides extend survival of prion-infected mice. JCI Insight. 2019;5. https://doi.org/10.1172/jci.insight.131175.
Minikel EV, Zhao HT, Le J, O’Moore J, Pitstick R, Graffam S, et al. Prion protein lowering is a disease-modifying therapy across prion strains, disease stages, and endpoints. bioRxiv. 2020. https://doi.org/10.1101/2020.03.27.011940.
Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(Pt 10):2348–59.
Article
CAS
PubMed
Google Scholar
Geschwind MD, Kuo AL, Wong KS, Haman A, Devereux G, Raudabaugh BJ, et al. Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease. Neurology. 2013;81:2015–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haïk S, Marcon G, Mallet A, Tettamanti M, Welaratne A, Giaccone G, et al. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:150–8.
Article
PubMed
CAS
Google Scholar
Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8:322ra9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Owen J, Beck J, Campbell T, Adamson G, Gorham M, Thompson A, et al. Predictive testing for inherited prion disease: report of 22 years experience. Eur J Hum Genet. 2014;22:1351–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Minikel EV, Vallabh SM, Orseth MC, Brandel J-P, Haïk S, Laplanche J-L, et al. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology. 2019;93(2):e125–e134. https://doi.org/10.1212/WNL.0000000000007745.
Vallabh SM, Minikel EV, Schreiber SL, Lander ES. Towards a treatment for genetic prion disease: trials and biomarkers. Lancet Neurol. 2020;19:361–8.
Article
CAS
PubMed
Google Scholar
Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer’s disease: implications for prevention trials. Neuron. 2014;84:608–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10:204–16.
Article
CAS
PubMed
Google Scholar
Cortelli P, Perani D, Montagna P, Gallassi R, Tinuper P, Provini F, et al. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain. 2006;129(Pt 3):668–75.
Article
PubMed
Google Scholar
Cohen OS, Chapman J, Korczyn AD, Nitsan Z, Appel S, Hoffmann C, et al. Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol. 2015;262:604–13.
Article
CAS
PubMed
Google Scholar
Rudge P, Jaunmuktane Z, Hyare H, Ellis M, Koltzenburg M, Collinge J, et al. Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease. Brain. 2019;142(3):760–70. https://doi.org/10.1093/brain/awy358.
Steinacker P, Blennow K, Halbgebauer S, Shi S, Ruf V, Oeckl P, et al. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease. Sci Rep. 2016;6:38737.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abu-Rumeileh S, Steinacker P, Polischi B, Mammana A, Bartoletti-Stella A, Oeckl P, et al. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia. Alzheimers Res Ther. 2019;12:2.
Article
PubMed
PubMed Central
CAS
Google Scholar
Novi G, Canosa A, Nobili F, Bongianni M, Zanusso G, Balestrino M, et al. Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease. Eur J Neurol. 2018;25:e127–8.
Article
CAS
PubMed
Google Scholar
Kovacs GG, Andreasson U, Liman V, Regelsberger G, Lutz MI, Danics K, et al. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort. Eur J Neurol. 2017;24:1326–e77.
Article
CAS
PubMed
Google Scholar
Abu Rumeileh S, Lattanzio F, Stanzani Maserati M, Rizzi R, Capellari S, Parchi P. Diagnostic accuracy of a combined analysis of cerebrospinal fluid t-PrP, t-tau, p-tau, and Aβ42 in the differential diagnosis of Creutzfeldt-Jakob disease from Alzheimer’s disease with emphasis on atypical disease variants. J Alzheimers Dis. 2017;55:1471–80.
Thompson AGB, Luk C, Heslegrave AJ, Zetterberg H, Mead SH, Collinge J, et al. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression. J Neurol Neurosurg Psychiatry. 2018;89(9):955–61. https://doi.org/10.1136/jnnp-2017-317793.
Staffaroni AM, Kramer AO, Casey M, Kang H, Rojas JC, Orrú CD, et al. Association of blood and cerebrospinal fluid tau level and other biomarkers with survival time in sporadic Creutzfeldt-Jakob disease. JAMA Neurol. 2019;76:969–77.
Article
PubMed Central
PubMed
Google Scholar
Orrú CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. 2015;6(1). https://doi.org/10.1128/mBio.02451-14.
Vallabh SM, Nobuhara CK, Llorens F, Zerr I, Parchi P, Capellari S, et al. Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. PNAS. 2019;116:7793–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Article
PubMed
PubMed Central
Google Scholar
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Article
PubMed
Google Scholar
Homack S, Lee D, Riccio CA. Test review: Delis-Kaplan executive function system. J Clin Exp Neuropsychol. 2005;27(5):599–609.
Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms and commentary. 3rd ed. Oxford: Oxford University Press; 2006.
Reitan RM, Wolfson D. Halstead-Reitan neuropsychological battery. Tucson: Neuropsychology Press; 1993.
Google Scholar
Souillard-Mandar W, Davis R, Rudin C, Au R, Libon DJ, Swenson R, et al. Learning classification models of cognitive conditions from subtle behaviors in the digital clock drawing test. Mach Learn. 2016;102:393–441.
Article
PubMed
Google Scholar
Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. Cognition assessment using the NIH Toolbox. Neurology. 2013;80(11 Suppl 3):S54–64.
Article
PubMed
PubMed Central
Google Scholar
Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20:444–58.
Article
PubMed
Google Scholar
Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.
Article
CAS
PubMed
Google Scholar
Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The Measurement of Everyday Cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008;22:531–44.
Article
PubMed
PubMed Central
Google Scholar
Farias ST, Mungas D, Harvey DJ, Simmons A, Reed BR, DeCarli C. The Measurement of Everyday Cognition (ECog): development and validation of a short form. Alzheimers Dement. 2011;7:593–601.
Article
PubMed Central
Google Scholar
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
Article
CAS
PubMed
Google Scholar
Thompson AGB, Lowe J, Fox Z, Lukic A, Porter M-C, Ford L, et al. The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain. 2013;136(Pt 4):1116–27.
Article
PubMed
Google Scholar
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–14.
Article
CAS
PubMed
Google Scholar
Capellari S, Vital C, Parchi P, Petersen RB, Ferrer X, Jarnier D, et al. Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family. Neurology. 1997;49:133–41.
Article
CAS
PubMed
Google Scholar
Dorey A, Tholance Y, Vighetto A, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. JAMA Neurol. 2015;72:267–75.
Article
PubMed
Google Scholar
Gaetani L, Höglund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P, et al. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. 2018;10. https://doi.org/10.1186/s13195-018-0339-1.
Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine. 2015;3:135–40.
Article
PubMed
PubMed Central
Google Scholar
Orrù CD, Groveman BR, Hughson AG, Manca M, Raymond LD, Raymond GJ, et al. RT-QuIC assays for prion disease detection and diagnostics. Methods Mol Biol. 1658;2017:185–203.
Google Scholar
Orrú CD, Groveman BR, Raymond LD, Hughson AG, Nonno R, Zou W, et al. Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains. PLoS Pathog. 2015;11(6):e1004983. https://doi.org/10.1371/journal.ppat.1004983.
Minikel EV, Kuhn E, Cocco AR, Vallabh SM, Hartigan CR, Reidenbach AG, et al. Domain-specific quantification of prion protein in cerebrospinal fluid by targeted mass spectrometry. Mol Cell Proteomics. 2019;18(12):2388–400. https://doi.org/10.1074/mcp.RA119.001702.
Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, et al. Cerebrospinal fluid total prion protein in the spectrum of prion diseases. Mol Neurobiol. 2018.
Trombetta BA, Carlyle BC, Koenig AM, Shaw LM, Trojanowski JQ, Wolk DA, et al. The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease. PLoS One. 2018;13. https://doi.org/10.1371/journal.pone.0193707.
Parchi P, Petersen RB, Chen SG, Autilio-Gambetti L, Capellari S, Monari L, et al. Molecular pathology of fatal familial insomnia. Brain Pathol. 1998;8:539–48.
Article
CAS
PubMed
Google Scholar
Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem. 1996;271:12661–8.
Article
CAS
PubMed
Google Scholar
Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, Watson N, et al. Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron. 2009;63:438–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watts JC, Giles K, Bourkas MEC, Patel S, Oehler A, Gavidia M, et al. Towards authentic transgenic mouse models of heritable PrP prion diseases. Acta Neuropathol. 2016;132:593–610.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, et al. Targeting huntingtin expression in patients with Huntington’s disease. N Engl J Med. 2019. https://doi.org/10.1056/NEJMoa1900907.
Orrù CD, Hughson AG, Race B, Raymond GJ, Caughey B. Time course of prion seeding activity in cerebrospinal fluid of scrapie-infected hamsters after intratongue and intracerebral inoculations. J Clin Microbiol. 2012;50:1464–6.
Article
PubMed
PubMed Central
Google Scholar
Tamgüney G, Francis KP, Giles K, Lemus A, DeArmond SJ, Prusiner SB. Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A. 2009;106:15002–6.
Article
PubMed
PubMed Central
Google Scholar
Hwang D, Lee IY, Yoo H, Gehlenborg N, Cho J-H, Petritis B, et al. A systems approach to prion disease. Mol Syst Biol. 2009;5:252.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hirouchi M. Neurofilament light chain (NfL) as a possible biomarker for drug efficacy in mouse models of neurodegenerative diseases. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738495/. Accessed 28 Oct 2019.
Google Scholar
Llorens F, Barrio T, Correia Â, Villar-Piqué A, Thüne K, Lange P, et al. Cerebrospinal fluid prion disease biomarkers in pre-clinical and clinical naturally occurring scrapie. Mol Neurobiol. 2018;55:8586–91.
Article
CAS
PubMed
Google Scholar
Satoh K, Nakaoke R, Nishiura Y, Tsujino A, Motomura M, Yoshimura T, et al. Early detection of sporadic CJD by diffusion-weighted MRI before the onset of symptoms. J Neurol Neurosurg Psychiatry. 2011;82:942–3.
Article
PubMed
Google Scholar
Verde F, Ticozzi N, Messina S, Calcagno N, Girotti F, Maderna L, et al. MRI abnormalities found 1 year prior to symptom onset in a case of Creutzfeldt-Jakob disease. J Neurol. 2016;263:597–9.
Article
PubMed
Google Scholar
Terasawa Y, Fujita K, Izumi Y, Kaji R. Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset. J Neurol Sci. 2012;319:130–2.
Article
PubMed
Google Scholar
Zanusso G, Camporese G, Ferrari S, Santelli L, Bongianni M, Fiorini M, et al. Long-term preclinical magnetic resonance imaging alterations in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2016;80:629–32.
Article
PubMed
Google Scholar
Mattsson N, Rosén E, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology. 2012;78:468–76.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mattsson N, Andreasson U, Zetterberg H, Blennow K. Alzheimer’s Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74:557–66.
Article
PubMed
PubMed Central
Google Scholar
Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem. 2001;47:1776–81.
Article
PubMed
Google Scholar
Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther. 2018;10:3.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sano K, Satoh K, Atarashi R, Takashima H, Iwasaki Y, Yoshida M, et al. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay. PLoS One. 2013;8:e54915.
Article
CAS
PubMed
PubMed Central
Google Scholar
Blennow K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, Karch A, Vidal E, et al. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. J Neurol Neurosurg Psychiatry. 2019;90:846–53.
Article
PubMed
Google Scholar
Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease. Alz Res Therapy. 2020;12:21.
Article
Google Scholar
Takada LT, Kim M-O, Cleveland RW, Wong K, Forner SA, Gala II, et al. Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature. Am J Med Genet B Neuropsychiatr Genet. 2017;174:36–69.
Article
PubMed
PubMed Central
Google Scholar